Pfizer’s UpJohn franchise is merging with Mylan- the troubled EpiPen manufacturer shrouded in price fixing controversies.

London Stock Exchange acquires Refinitiv, Reuters' divested business to Blackstone last year, for $27bn.

Weak investor appetite led AB InBev to scrap its plan to list its Asian business and instead to sell its Australian unit to Japan's Asahi.

US drugmaker AbbVie launched a $63 billion bid for Botox maker Allergan in what will result in the world’s fifth largest drug company.

Raytheon, the aerospace behemoth, is looking to merge with United Technologies billion to hedge risk in the face of a cyclical downturn.

General Electric sold its Life Sciences division to Danaher Corporation for $21.4bn, as part of GE's plan to push further its aviation.

Roche, the Swiss drugs group, has won a two-way race to acquire Spark Therapeutics, Inc. for $4.8bn.

Renesas Electronics has decided to acquire IDT to diversify its product offerings until these technologies make a pronounced impact.

The recent acquisition of Middle-Eastern rival Careem marks a fundamental strategic shift for Uber.

Two months after the announcement of Fiserv-FirstData merger, FIS launched a $43bn bid on British payments processing rival Worldpay.

Will NVIDIA succeed in integrating Mellanox Technologies‘ operations with their own datacenter market of high-performance computing?

In an attempt to ride the wave of technology sweeping the restaurant sector, Takeaway.com is acquiring the German company Delivery Hero.

Merck's strategic acquisition of Antelliq leads the path to sustainable and significant investments in agricultural technologies.

Eli Lilly’s most recent acquisition marks a clear strategic path towards immunotherapy and oncology for the firm.

Barrick Gold’s announcement of a hostile $18bn offer for its closest rival Newmont Mining came as a surprise to investors.

Amidst a pharma spending spree, Johnson & Johnson $3.4bn acquisition of Auris Health is a move towards turning around its medical devices.

In what is the first major banking merger in years, BB&T and SunTrust, two prominent super-regional banks in the US, have agreed to unite.

DSV launched a $4.1bn bid for Swiss rival Panalpina who faces increasing pressure from activist investor Cevian Capital to sell itself.

The $114bn merger between Abu Dhabi Commercial Bank and Union National Bank propagated the consolidation trend in the overbanked GCC region.

Cigna’s $70bn acquisition of Express Scripts was the biggest deal by volume announced in 2018, but was it the smartest?